Search alternatives:
gap decrease » gain decreased (Expand Search), step decrease (Expand Search), _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
gap decrease » gain decreased (Expand Search), step decrease (Expand Search), _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3821
CaCl<sub>2</sub> and MnCl<sub>2</sub> treatment significantly reduced Pol I occupancy on the rDNA template.
Published 2025“…If the <i>p</i>-value < 0.05, that was deemed a significant difference between the two treatment groups and was indicated with either a green (increased occupancy) or black (decreased occupancy) line below the histogram for the CaCl<sub>2</sub> treated samples with respect to the untreated samples. …”
-
3822
Data Sheet 2_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.pdf
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3823
Table 1_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3824
Table 3_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3825
Table 4_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3826
Table 2_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3827
Data Sheet 1_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.pdf
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3828
Table 6_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3829
Table 5_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
Published 2025“…Additionally, RT-qPCR results revealed decreased levels of VAV3 (vav guanine nucleotide exchange factor 3, a target of miR-499a-5p) and IGF1 (insulin like growth factor 1, a target of miR-576-5p) in the CSF samples of NB patients.…”
-
3830
Data Sheet 1_Capsaicin induces ferroptosis via suppression of SLC7A11 activity and upregulation of ACSL4 mediated by AMPK in tongue squamous cell carcinoma.zip
Published 2025“…Moreover, CAP inhibited glutamate release while enhancing BECN1-SLC7A11 binding, suggesting a reduction in SLC7A11 activity through the AMPK/BECN1 pathway. …”
-
3831
-
3832
-
3833
-
3834
-
3835
-
3836
-
3837
-
3838
-
3839
-
3840